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Abstract
Background: Falciparum Malaria, an infectious disease caused by the apicomplexan parasite Plasmodium falciparum,i s
among the leading causes of death and morbidity attributable to infectious diseases worldwide. In Gabon, Central Africa,
one out of four inpatients have severe malarial anemia (SMA), a life-threatening complication if left untreated. Emerging
drug resistant parasites might aggravate the situation. This case control study investigates biomarkers of enhanced
hemolysis in hospitalized children with either SMA or mild malaria (MM).
Methods and Findings: Ninety-one children were included, thereof 39 SMA patients. Strict inclusion criteria were chosen to
exclude other causes of anemia. At diagnosis, erythrophagocytosis (a direct marker for extravascular hemolysis, EVH) was
enhanced in SMA compared to MM patients (5.0 arbitrary units (AU) (interquartile range (IR): 2.2–9.6) vs. 2.1 AU (IR: 1.3–3.9),
p,0.01). Furthermore, indirect markers for EVH, (i.e. serum neopterin levels, spleen size enlargement and monocyte
pigment) were significantly increased in SMA patients. Markers for erythrocyte ageing, such as CD35 (complement receptor
1), CD55 (decay acceleration factor) and phosphatidylserine exposure (annexin-V-binding) were investigated by flow
cytometry. In SMA patients, levels of CD35 and CD55 on the red blood cell surface were decreased and erythrocyte removal
markers were increased when compared to MM or reconvalescent patients. Additionally, intravascular hemolysis (IVH) was
quantified using several indirect markers (LDH, a-HBDH, haptoglobin and hemopexin), which all showed elevated IVH in
SMA. The presence of both IVH and EVH predicted the need for blood transfusion during antimalarial treatment (odds ratio
61.5, 95% confidence interval (CI): 8.9–427). Interestingly, this subpopulation is characterized by a significantly lowered
reticulocyte production index (RPI, p,0.05).
Conclusions: Our results show the multifactorial pathophysiology of SMA, whereby EVH and IVH play a particularly
important role. We propose a model where removal of infected and non-infected erythrocytes of all ages (including
reticulocytes) by EVH and IVH is a main mechanism of SMA. Further studies are underway to investigate the mechanism and
extent of reticulocyte removal to identify possible interventions to reduce the risk of SMA development.
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Introduction
Malaria due to Plasmodium falciparum is the most important
parasitic disease worldwide; approximately 270 million people get
infected and 1 to 3 million deaths occur every year, most of them
in sub-Saharan Africa [1]. Most severely affected are children up
to the age of 5 years [2]. Complications leading to death include
severe malarial anemia (SMA), cerebral malaria, hypoglycemia,
lactic acidosis and convulsions. SMA is particularly common in
regions with high malaria endemicity. The World Health
Organization defines SMA as hemoglobin (Hb) level of below
5 g/dl plus a parasite count of more than 10,000 per ml blood [3].
In Lambare ´ne ´, Gabon, a hyperendemic area, SMA is one of the
most common complications of malaria which requires adjunct
therapy [4]. An epidemiological survey undertaken at the same
time period than the presented study showed that 25% of all 1
month to 10 years old hospitalized malaria patients had severe
anemia, 95% of whom were younger than 5 years old [5]. The
recent literature shows a decline of malaria incidence both in
urban and rural regions of Gabon, which is the same in some other
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10038African regions [6,7,8]. This decrease of malaria incidence might
indicate the success of recent drug policies and of prevention
measures like treated bed nets. In The Gambia, the overall decline
of malaria endemicity also led to a reduced frequency of SMA [7].
Nevertheless, recent non-published surveys show that the frequen-
cy of SMA in Lambare ´ne ´ stays rather stable. This might be
explained by the supraregional importance of the Albert
Schweitzer Hospital in Lambare ´ne ´. The severe cases often come
from small villages located far away from the hospital, which are
not covered by national malaria prevention programs.
Treatment of SMA consists of blood transfusion and antima-
larial treatment. In most sub-Saharan African countries, safe blood
transfusions are difficult to perform because of inadequate blood
banks, difficult access to well tested donors, and prejudices due to a
bad reputation of blood transfusions [9]. In addition, testing,
processing, and storage of blood products is generally far from a
high standard and poses a substantial risk of transfusion reactions
and transmission of infectious diseases [10]. To avoid the risk
associated with blood transfusions it was proposed to postpone
transfusion as long as SMA patients are clinically stable [2,11,12].
Other measures to reduce the need for transfusions than risk-
group identification have not been tested thus far.
A rational approach to identify alternative treatments is difficult
because the etiology of SMA is not known. Current hypotheses about
the development of SMA were reviewed recently [13,14], and the
only consensus is about the lack of detailed knowledge we have,
especially because animal models are only partly informative and few
clinicalstudiesinvestigatedSMAsensu stricto(Hbconcentration ,5g /
dl or hematocrit ,15% and no other cause of anemia).
Generally, disturbance of the equilibrium between production
and clearance of red blood cells (RBCs) leads to anemia. Although
decreased erythropoiesis may have an additive role [15,16],
cumulated data suggests that enhanced clearance of RBCs is
critical for the development of SMA. Direct parasite-mediated
destruction of RBCs does not explain the amount of anemia in
SMA and mathematical modeling predicts that lysis of non-
parasitized erythrocytes has an important role in the development
and the degree of anemia [17,18], which confirms the clinical
notion that SMA in African children is not associated with high
parasitemias. Old or altered RBCs are removed by phagocytosis
(extravascular hemolysis, EVH) or lysis (intravascular hemolysis,
IVH), although in most hemolytic disease states both mechanisms
act at the same time. EVH is usually deduced from indirect and
imprecise markers such as spleen size, whereas IVH can be
estimated from serum concentrations of biomarkers such as
haptoglobin, hemopexin, lactate dehydrogenase (LDH), or
alpha-hydroxybutyrate dehydrogenase (a-HBDH). We recently
developed a method to measure erythrophagocytic activity of
monocytes from malaria patients more accurately [19] and used it
in the present study to characterize RBC removal during SMA.
Several mechanisms have been proposed to contribute to RBC
destruction during malaria, including increased release of oxygen
radicals [20], presumably leading to stiffening of the RBC
membrane [21,22], and exhaustion of complement receptor 1
(CD35) and decay accelerating factor (CD55) on RBC mem-
branes, which leads to sensitization for phagocytosis [23,24]. All
these concepts postulate an ‘‘accelerated aging’’ phenotype of
RBCs during malaria that leads to clearance of RBCs by
unspecific mechanisms. If, in contrast, predominantly reticulocytes
and young RBCs would be removed from the circulation (such as
in thalassemias) by a malaria-induced factor, its contribution to the
development of SMA would be disproportionally high and might
Figure 1. Study-flow chart.
doi:10.1371/journal.pone.0010038.g001
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recovery from SMA [25].
In the present report we show that SMA patients have increased
levels of erythrophagocytosis and IVH. The odds for a blood
transfusion in addition to antimalarial treatment are high when
erythrophygocytosis plus IVH are elevated. Interestingly, these
patients are characterized by significantly low levels of reticulo-
cytes. This indicates that the age-structure of the removed RBC
population is crucial for the development of clinically unstable
SMA. Understanding the etiology of this might lead to an
alternative management of this complication.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki and approved by the ethics
committees of the International Foundation for the Albert
Schweitzer Hospital in Lambare ´ne ´ as well as the ethics committees
of the Universities of Mu ¨nster and Tu ¨bingen, Germany. Written
informed consent was obtained from parents or guardians of all 91
study patients. All patients were children of pre-school age and, in
addition to written informed consent by the parent, assent was
sought where possible.
Patients and study design
The study took place at the Medical Research Unit (MRU) of
the Albert Schweitzer Hospital in Lambare ´ne ´, Gabon between
December 2003 and July 2005. In total 91 children, aged between
one and six years, were admitted to the study. Admission criteria
were positive thick blood smears of above 1,000 P. falciparum
parasites per ml, mean corpuscular volume above 65 fl and no
sickle cell disease. Patients were recruited and stratified into three
Hb-concentration strata with matched age between strata
(Figure 1). For statistical analysis, patients were allocated to a
severe malarial anemia group (SMA, RBC ,2.8 Mio/ml), and a
moderate malarial anemia group (RBC .2.8 Mio/ml). All patients
were hospitalized and treated with quinine and clindamycin, the
current standard for the treatment of SMA at the Albert
Schweitzer Hospital [26]. Patients received blood transfusion or
any other supportive treatment upon clinical judgment of the
clinician. Patients were actively followed up for two months
(treatment period day 0 to day 4, control visits on day 14, day 28
and day 56) to allow hematological values to return to baseline. If
they had a parasitemic episode during follow-up, patients were
followed for another 2 months after their last infection. From each
patient, 5 ml of heparinized blood and 1 ml of EDTA blood was
obtained directly before treatment antimalarial treatment and
blood transfusion. Total leukocyte counts and RBC values were
measured using a Cell Dyn 3000 (Abbott). Differential blood
counts and counting of hemozoin - positive phagocytes were done
on thin blood smears [27,28]. Reticulocyte counting was done on
brilliant cresyl blue stained samples, and reticulocyte production
index was calculated according to standard procedures [29]. The
presence of hemoglobin F, S or C was assessed by hemoglobin
electrophoresis and Kato-Katz smears were done to test for
intestinal parasites including hookworm infections. Spleen volume
was measured by ultrasonography on admission and after
reconvalescence. The relative spleen volume was calculated as
the quotient of spleen volume on admission and after reconvales-
cence. In addition, palpable subcoastal spleen enlargement was
estimated on admission. The simplified Multiple Organ Dysfunc-
tion Score (sMODS; Table S1, Table S2, Table S3 and Table S4)
was estimated as previously described [30]. Care - givers of the
patients were asked for the duration of illness of the children and
detailed clinical history was taken.
Phagocytosis assay
Blood was processed within one hour after sampling and
phagocytosis assay were done as previously described [19]. Briefly,
monocytes were isolated by CD14
+ positive selection using magnetic
cell sorting (Miltenyi). RBCs from the same patient and, for the
positive and negative control, from one malaria naı ¨ve 0+ voluntary
blood donor were centrifuged, washed and stained with 5 nM
carboxy-fluorescein-diacetate-succinimidyl ester (CFDA). One batch
of control RBCs was opsonized with human anti-D IgG (1:20) to
serve as a positive control, the other was left untreated to serve as
negative control. The patients’ RBCs were not further treated. For
phagocytosis assay, 2610
5 monocytes were incubated for 4 hours at
37uC/5% CO2 with 100 fold numeric excess of the respective RBC
Table 1. Clinical data of anemic and non-anemic patients on admission.
Total study population (n=91) Group MM (n=52) Group SMA (n=39) p-value
Hb (g/dl) 8.0 (4.9–10.0) 10 (8.7–10.5) 4.9 (4.4–5.3) -
a
Hct (%) 23.9 (14.9–29.0) 28.1 (25.9–30.6) 14.3 (12.3–16.0) -
a
RBCs (10
6 cells/ml) 3.27 (2.19–3.90) 3.87 (3.50–4.30) 1.93 (1.60–2.30) -
a
Parasitemia (per ml) 20,200 (6,960–76,000) 23,800 (8,880–69,000) 12,000 (5,880–101,600) 0.81
b
Reticulocytes (%) 2.4 (1.4–5.2) 1.8 (1.3–2.5) 5.3 (2.3–10.6) ,0.0001
b
MCV (fl) 72.6 (68.6–76.8) 71.8 (67.9–76.0) 74.0 (69.3–78.1) 0.15
b
Age (months) 32 (22–50) 36 (23–53) 27 (20–43) 0.13
b
Weight (kg) 13.0 (10.8–15.0) 13.5 (11.0–15.0) 11.4 (9.8–14.0) 0.04
b
Height (cm) 89 (81–100) 90 (83–104) 87 (76–96) 0.12
b
# Sex (male/female) 45/46 26/26 19/20 1
c
# Sickle cell trait 8 6 2 0.46
c
# Blood transfusion 17 0 17 ,0.0001
c
MM: mild malaria, SMA: severe malarial anemia, Hb: hemoglobin, Hct: hematocrit, RBCs: red blood cells, MCV: mean corpuscular volume, results are in median
(interquartile ranges) and count data (#).
aparameter used for group definition - no p-value calculated,
bKruskal-Wallis rank sum test,
cx
2-test.
doi:10.1371/journal.pone.0010038.t001
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non-phagocytozed RBCs were lysed and monocytes containing
ingested RBCs were analyzed by flow cytometry. Data was expressed
as relative phagocytosis to negative control. Hence, data is presented
as relative phagocytosis activity for positive control and the sample
from the same patient (autologous RBCs).
Surface staining of RBCs
Surface markers of RBCs were measured by flow cytometry. All
antibodies wereobtained from BD Biosciences if not stated otherwise.
Fifty ml blood were washed once in phosphate buffered saline
complemented with 2 mM EDTA and 0.5% BSA (PBS-EB) and 5 ml
of RBC pellet was stained subsequently with one of the following
antibodies: FITC anti-human C3c (DakoCytomation), FITC anti-
human CD35, FITC anti human CD55, FITC anti human CD59,
FITC anti-human IgG (Biozol), or appropriate isotype controls.
Samples were incubated for 30 minutes at room temperature in the
dark, washed thrice in PBS and measured by flow cytometry.
Another 5 ml of blood was washed once in annexin V binding buffer
(10 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM CaCl2), stained
with annexin V and measured immediately by cytometry.
Serum parameters
Neopterin (MP Biomedicals) and hemopexin (GenWay Biotech)
quantificationwasperformedbyELISAusingcommerciallyavailable
kits according to the respective manufacturers’ specifications. LDH,
a-HBDH and haptoglobin were measured by the central laboratory
of the University Hospital Mu ¨nster according to standard procedures.
Flow cytometry
Flow cytometry analysis of RBC surface markers and phago-
cytosis was done on a Partec CyFlow SL Cytometer equipped with
a 488 nm laser and detection at 515–550 nm. Data was acquired
and analyzed with FlowMax FCM v2.4f (Partec, Germany). Mean
fluorescence intensities were quantified using Weasel v2.6
(Cytometry Lab, The Walter and Eliza Hall Institute of Medical
Research, Australia). Monocytes and RBCs were gated on FSC –
SSC plots, the rate of fluorescent positive cells and fluorescence
intensity was acquired on FL-1-histograms.
Statistical analysis
The study was designed as a case-control study to identify
variables that discriminate malaria patients with and without
SMA. Variables associated with RBC production, RBC removal,
clinical and parasitological presentation were measured and
recorded. All patients received the same antimalarial treatment.
Recruitment in three age-matched Hb-strata resulted in two
populations with different degree of anemia. Post-hoc grouping of
severe and non-severe malaria was done by least square fit.
Severely anemic patients that required blood transfusions were
analyzed as a subgroup. All statistical analysis was done using JMP
v5.0.1 (SAS Institute) and R v2.7 [31]. Level of significance was set
at two-sided p=0.05 for all tests. Kruskal Wallis rank sum test was
used to compare continuous data among groups. Adjustment for
confounders (weight, age) has been carried out by logistic
regression analysis where indicated. Values indicated are medians
and interquartile ranges, if not stated otherwise. Counting data
was analyzed by x
2 or Fisher’s exact test.
Results
Patients
Throughout the study 495 malaria patients were referred to the
MRU and 91 patients were admitted to this study. Main causes for
exclusion were non-matching age, low MCV (an indicator of iron
deficiency or thalassemia), and logistics. At inclusion, eligible
patients were stratified according to age and hemoglobin
concentration (Figure 1). Analysis of the distribution of RBC
Figure 2. Phagocytosis rate in severe malarial anemia (SMA)
and mild malaria (MM) patients: The plot shows individual
values of relative phagocytosis of autologous samples (pa-
tients monocytes phagocytosing autologous RBCs) and posi-
tive control samples (patients monocytes phagocytosing anti-
D IgG opsonized control RBCs). Thick lines represent median
values. Phagocytosis rates were investigated on admission and after
reconvalescence on day 56. In A) phagocytosis rates are shown for SMA
patients. Phagocytosis rates of autologous samples at day 0 are as high
as positive control. On day 56, autologous sample is significantly lower
than positive control (p,0.05, # SMA - non-transfused,N SMA -
transfused). In B), phagocytosis rates of MM patients are illustrated.
Phagocytosis rates of autologous samples are significantly lower on day
0 as well as on day 56 (p,0.05, D MM).
doi:10.1371/journal.pone.0010038.g002
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Analysis of the study population was done on a grouped dataset
using a least square fit of RBC number on two normal
distributions to discriminate anemic (SMA; severe malarial
anemia) versus non-anemic (MM; mild malaria) children with a
cut-off value of 2.8610
6 RBCs/ml.
On admission no significant difference in parasitemia, age, height,
and MCV between SMA and MM patients was observed. Those
with SMA weighted less than MM patients, an observation that is
most probably due to dehydration as on follow-up no significant
difference was found (p=0.06). To exclude chronic malnutrition as
contributor to SMA, z-scores for ‘‘height for age’’, ‘‘weight for
height’’, and ‘‘weight for age’’ were estimated. No significant
differences were found in any of these scores (data not shown). As
expected, only SMA patients received blood transfusions (n=17) and
the percentage of reticulocytes was significantly higher in the SMA
compared to the MM group (Table 1). Sickle-cell trait carriers were
equally distributed between the groups. Two SMA patients died. A 3
year old boy presented with respiratory distress and signs of acute
renal insufficiency and died on the first day after admission. The
second, a 22 month old boy, died in a rural hospital about 200 km
from Lambare ´ne ´ two months after discharge from the MRU.
Extensive efforts to discover the cause of death by verbal autopsy and
studying the patient’s records did not reveal an obvious explanation.
Red blood cell turnover
Extravascular hemolysis. To estimate the level of
erythrophagocytosis, monocytes were isolated and incubated
with fluorescently labeled RBCs from the patient (‘‘autologous
RBCs’’) or from a healthy donor with (‘‘positive control’’) or
without (‘‘negative control’’) opsonisation with human anti-D IgG
antibodies. On admission, erythrophagocytosis of autologous
RBCs was higher in SMA (median: 5.0 AU) compared to MM
patients (median: 2.1 AU, p,0.01), whereas in reconvalescent
children, erythrophagocytosis was not significantly different
(p=0.94; Figure 2a and b). Erythrophagocytosis of positive
control RBCs was similar in all conditions tested and within the
range of autologous RBCs from SMA patients on admission
(median: 4.3 AU).
Spleen size, a rough estimate of in vivo phagocytic activity, was
increased in SMA patients on admission. Other markers of
monocyte activation such as neopterin [32] (p,0.05) and the
number of hemozoin containing monocytes on thin blood smears
(p,0.0001) were also significantly different between SMA and
MM children (Table 2).
Removal tags on RBCs. A possible cause of enhanced
erythrophagocytosis is the exposure of removal signs on the RBC
surface (Table 3). CD35 and CD55, two complement receptors
on the surface of RBCs were significantly down-regulated in
SMA patients, whereas annexin V binding was increased in
anemic patients. Expression of CD59 and C3 - fragment binding
on the surface were not significantly different between the two
groups. No association of CD35 or CD55 expression with age
was observed.
Intravascular hemolysis on admission. In addition to
EVH, IVH might contribute to the development of SMA. To
investigate IVH we measured haptoglobin, hemopexin, LDH, a-
HBDH, and hemoglobinuria. LDH and a-HBDH concentrations
were increased in SMA compared to MM patients whereas
haptoglobin and hemopexin concentrations were lower (Table 4).
Table 2. Surrogate markers for extravascular hemolysis and disease severity on admission.
Total study population (n=91) Group MM (n=52) Group SMA (n=39) p-value
a
Pigment in Monocytes (%) 10 (4–20) 6 (2–10) 19 (9–28) ,0.0001
Relative spleen volume 2.7 (2.0–3.8) 2.5 (1.9–3.1) 3.0 (2.5–4.2) ,0.05
Spleen (cm) 2 (0–3) 1 (0–2) 2 (2–4) ,0.0001
Neopterin (ng/ml) 7.2 (5.7–9.9) 6.5 (5.3–8.6) 8.1 (6.4–12.3) ,0.05
Lactate (mmol/l) 2.6 (2.0–3.3) 2.3 (1.8–2.9) 2.9 (2.3–4.3) ,0.005
sMODS 14 (13–15) 13 (12–14) 15 (14–17) ,0.0001
MM: mild malaria, SMA: severe malarial anemia, relative spleen volume: calculated as spleen volume at recruitment/spleen volume after reconvalescence (measured by
sonography), Spleen (cm) represents subcoastal spleen enlargement, sMODS: simplified multi organ dysfunction score, results are in median (interquartile ranges).
aKruskal-Wallis rank sum test.
doi:10.1371/journal.pone.0010038.t002
Table 3. Erythrocyte surface makers on admission.
Total study population (n=91) Group MM (n=52) Group SMA (n=39) p-value
a
Annexin V (%) 0.6 (0.3–1.3) 0.5 (0.3–0.7) 1.1 (0.6–1.9) ,0.005
CD35 (MFI) 4.1 (3.9–4.8) 4.3 (4.0–5.0) 4.0 (3.7–4.5) ,0.05
CD55 (MFI) 5.8 (5.1–7.1) 6.4 (5.5–7.8) 5.5 (4.8–6.5) ,0.05
CD59 (MFI) 53.3 (44.5–71.0) 51.4 (44.5–68.5) 56.3 (44.1–71.0) 0.82
C3c (MFI) 3.5 (1.2–5.8) 3.6 (3.2–4.3) 3.6 (3.5–4.0) 0.55
IgG (%) 4.6 (4.0–5.6) 4.3 (3.9–5.3) 5.0 (4.0–5.9) 0.08
MM: mild malaria, SMA: severe malarial anemia, %: percentage of fluorescence positive cells, MFI: mean fluorescence intensity, IgG: immunoglobulin G, results are in
median (interquartile ranges).
aKruskal-Wallis rank sum test.
doi:10.1371/journal.pone.0010038.t003
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respect to hemoglobinuria (p=0.28).
Interaction of IVH and erythrophagocytosis. IVH - EVH
interaction and its effect on the severity of anemia was
investigated. To do this, thresholds for elevated intravascular
and extravascular hemolysis were defined and patients were
grouped accordingly. IVH was estimated by two variables:
hemopexin and a-HBDH. High IVH was defined as a
hemopexin level below the median of the all patients (8.7 mg/dl)
plus an a-HBDH of above median level (355 U/l). A combination
of both factors increases specificity of the IVH estimate.
Autologous erythrophagocytosis activity represented EVH. The
threshold for elevated phagocytosis was defined by the median
positive control erythrophagocytosis level seen in all patients
(4.3 AU). Figure 3a shows the interaction between those three
variables. Patients with enhanced hemolysis in all three variables
were grouped together (high hemolysis; HH) and compared to the
remaining individuals.
HH patients had a median of 1.46610
6 RBCs/ml (IR:
1.28610
6–2.14610
6 RBCs/ml), while patients with low hemolysis
had a median of 3.58610
6 RBCs/ml (IR: 2.54610
6–
4.23610
6 RBCs/ml, p,0.001). Most notably, HH patients had
an elevated risk to receive a blood transfusion during hospitaliza-
tion (odds ratio 61.5 (CI: 8.9–427)). Additionally, HH patients had
a significantly elevated sMODS of 17 [IR: 16–19] versus 12 [IR:
11–13] (p,0.0005) in non-HH patients. High hemolysis was not
associated with any of the erythrocyte age markers investigated
(data not shown). Hence erythrocyte aging cannot explain the
higher odds for blood transfusion in these patients.
The reticulocyte production index (RPI) is a marker for
erythropoietic output. It estimates the quantity of reticulocytes in
the peripheral blood, corrected for the degree of anemia and
therefore is a good measure of whether the reticulocyte production
is adequate for the degree of anemia present [29]. In our patient
population, HH - children had a significantly reduced RPI
(figure 3b, p,0.05, logistic regression). This finding indicates that
a subpopulation of malaria patients with high IVH plus EVH have
a high risk of receiving blood transfusions and suffer from
inadequately low reticulocyte numbers.
Follow-up
Markers of disease were measured again after 2 months of a
parasite-free period. All measured variables were not significantly
different between SMA and MM (data not shown). The two
groups evolved into one homogeneous population with little
variability. Hemoglobin levels raised to 10.6 g/dl, the reticulocyte
counts dropped back to normal levels. In both, the SMA and MM
group, phagocytosis levels were significantly lower at day 56 than
at day 0.
Discussion
The etiology of severe malarial anemia, one of the most
frequent complications in malaria, recently regained interest.
Several mechanisms seem to contribute to anemia during malaria,
with pronounced differences in different patient populations and
animal models. Proposed key mechanisms are suppressed
erythropoiesis [15], removal of parasitized erythrocytes [33,34],
enhanced clearance of both parasitized and unparasitized
erythrocytes by the spleen and other phagocytes [35,36,37,38],
and intravascular lysis [23]. The relative contribution and
interaction of these individual factors on SMA is unknown.
Recently, an interesting and challenging hypothesis was presented
on the basis of studies in humans [35,37,39]: complement and
complement regulatory proteins are dysregulated in SMA and lead
to enhanced removal of erythrocytes because complement-binding
receptors (CD35 and CD55) on erythrocytes have been consumed
by excessive amounts of activated complement in serum and leave
the RBC prone to lysis. In addition, this finding provides an
explanation for the increased risk to develop SMA in infancy:
children between 1 and 3 years constitutively express reduced
levels of complement regulators on their RBC surface and
therefore the probability to develop SMA is higher [40].
Nevertheless, these results were not confirmed in a subsequent
study from Ghana [23], where no correlation of CD35 and CD55
expression levels and anemia status were found. Other proposed
mechanisms are based on reduced deformability of RBCs as an
effect of oxidative damage due to proinflammatory cytokines and
parasite products [22,41].
In this study we reproduced some findings of Waitumbi et al.
[35,37,39]: SMA patients had reduced CD35 and CD55
expression on the RBC surface. In addition, we observed
enhanced ex vivo erythrophagocytosis in SMA patients. This
confirms results from previous pilot studies [19]. Increased ex vivo
erythrophagocytosis is accompanied by surrogate markers of
phagocyte activation like neopterin and spleen size. However, we
were unable to detect an association between complement or
immunoglobulin deposition on freshly isolated RBCs. Further-
more, CD35 and CD55 RBC surface expression was not
associated with age. In contrast to complement- and immuno-
globulin-binding, SMA children showed elevated phosphatidyl-
serine exposure on RBC surface, a removal marker that tags old or
damaged RBC for phagocytosis [42,43]. In SMA patients the rate
of RBC removal outcompetes the rate of RBC production. Based
on a static model it has been proposed that half of the drop of
hematocrit due to malaria occurred before admission [44]. This
direct interpretation may be oversimplistic because dynamic rates
(and not a fixed absolute number of removed erythrocytes)
determines the development of anemia. Turn-over of erythrocytes
Table 4. Markers of intravascular hemolysis on admission.
Total study population (n=91) Group MM (n=52) Group SMA (n=39) p-value
a
Haptoglobin (mg/dl) 0 (0–73.5) 41 (0–110) 0 (0–0) ,0.0001
Hemopexin (mg/dl) 8.7 (4.8–10.8) 10.0 (8.8–11.3) 4.2 (1.9–6.3) ,0.0001
LDH (U/l) 432 (325–582) 350 (309–408) 579 (454–858) ,0.0001
a-HBDH (U/l) 355(281–523) 298 (250–348) 522 (414–694) ,0.0001
MM: mild malaria, SMA: severe malarial anemia, LDH: lactate dehydrogenase, a-HBDH: alpha hydroxybutyrate dehydrogenase, results are in median (interquartile
ranges).
aKruskal-Wallis rank sum test.
doi:10.1371/journal.pone.0010038.t004
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research may provide us with new insights.
Most hypotheses on the development of SMA and removal of
infected RBC rely on the assumption that mature and old RBCs
are removed from the circulation by EVH and IVH. Our results
point to an alternative direction: association of high hemolysis
(HH) with low RPI infers an important effect on reticulocytes and
young RBCs in SMA. Although we cannot exclude that in
addition erythropoiesis is negatively affected in SMA patients, this
finding is of particular importance because removal of reticulo-
cytes and young erythrocytes (which contribute disproportionately
to the total number of circulating erythrocytes in SMA patients) by
erythrophagocytosis will stunt compensatory erythropoiesis.
We can only speculate on the mechanism of reticulocyte removal.
Possibly, stress erythropoiesis, a phenotype present in diseases like
thalassemia, may be involved. In thalassemia, erythropoietic cells are
oxidatively stressed by the accumulation of precipitated a-globin-
chain tetramers. Consequently, only few erythropoietic cells undergo
full maturation and are removed as reticulocytes either in the bone
marrow or the spleen. Hemozoin, a parasite byproduct released at
the burst of infected erythrocytes after schizogeny, has been proposed
to contribute to SMA. It has been proposed that hemozoin may,
together with an elevated TNF-a concentration, inhibit erythropoi-
esis [15,46]. An effect of hemozoin on early erythropoietic
progenitors was not the focus of this study, but an effect on
reticulocytes and young circulating RBC might be present through
the hemozoin-mediated oxidative stress on RBC membranes [47].
Since SMA in African children is frequently a chronic disease, very
low RBC numbers are supported. This observation led to the clinical
practice to delay blood transfusions as long as possible unless patients
are clinicallyunstable. In line with our hypothesis of preferential (or at
leastequivalent)removalofyoungerythrocytesandthereforestunting
of compensatory erythropoiesis in SMA, we observed that high IVH
and high EVH increased odds for blood transfusion and associates
with low RPI. So far, increased IVH and EVH in SMA were
attributed to the lysis of infected and prematurely aged RBCs.
Surprisingly little is known about the age structure of RBC
populations in SMA.
A drawback of our study design is that we cannot explore the
early phases of disease development, since SMA is not amenable to
a prospective study design because the required close follow up to
detect early hematological changes prevents the development of
SMA [40].
This study investigated young children in a hyperendemic area
in Central Africa, one of the populations mostly affected by SMA.
Stringent selection of patients and control or exclusion of
interfering factors such as age, iron deficiency, malnutrition or
hemoglobinopathies allowed the specific investigation of SMA. In
conclusion, we propose that hemolytic removal of reticulocytes
and young RBCs stunts compensatory erythropoiesis and
therefore is a critical step for the development of clinically
unstable SMA. Quantitative studies of the age pattern of removed
erythrocyte populations and discovery of molecular events that
determine SMA-associated removal of reticulocytes should give
new and interesting insight in the development of SMA and might
lead to urgently needed new interventions.
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Figure 3. Distribution of enhanced intravascular and extravas-
cularhemolysis acrossthepatientgroups and itscorrelationwith
reduced RPI: In figure A), a dot plot of a-HBDH vs. hemopexin
concentration, both makers for IVH, at presentation is shown on
the x and y axis, respectively. The size of the data symbols represents
erythrophagocytosis activity, a direct marker of EVH (the bigger the
symbol, the higher the autologous erythrophagocytosis). Classification
criteria for ‘‘elevated IVH and EVH’’ match for those symbols bigger than
the borderline levels shown in the plot and laying in the white region.
Figure B: The Group having both ‘‘elevated EVH and IVH’’ had significantly
lower reticulocyte productions indices than the other patients (p,0.05). D
MM; # SMA - non transfused;N SMA - blood transfused.
doi:10.1371/journal.pone.0010038.g003
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